Status:
UNKNOWN
Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Pain Management and Care
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a ce...
Eligibility Criteria
Inclusion
- Male or female aged 65 years old or more
- Patients having a prescription for physiotherapy
- Absence of contraindication to MEOPA
- Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus
- Patients whose reeducation project established by the physiotherapist
- Patients having agreed to participate in the study and having signed the consent
- Subjects affiliated to the social security system
Exclusion
- Patient requiring a ventilation in pure oxygen
- Patient with a consciousness deterioration preventing his cooperation
- Care under MEOPA during the period of the protocol and during the month which precedes
- Increase of the dosage of morphine of less than 48 hours Patient under guardianship
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT02230007
Start Date
June 1 2013
End Date
July 1 2015
Last Update
September 3 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pôle de Gérontologie Hôpital de Cimiez CHU de Nice
Nice, France, 06000
2
CHU de Nice
Nice, France, 06003